NRC — National Research Balance Sheet
0.000.00%
- $244.26m
- $302.73m
- $143.06m
- 86
- 72
- 26
- 65
Annual balance sheet for National Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 34.7 | 54.4 | 25 | 6.65 | 4.23 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 15.5 | 14.6 | 15.3 | 12.6 | 11.4 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 54.1 | 73.7 | 43.7 | 24.4 | 19.6 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 13 | 13.4 | 17.8 | 30.3 | 39.9 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 133 | 158 | 130 | 122 | 133 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 31.7 | 40.4 | 33.4 | 36.2 | 35.9 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 69.1 | 72.2 | 58.4 | 73.5 | 101 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 64.3 | 85.3 | 72 | 49 | 31.3 |
Total Liabilities & Shareholders' Equity | 133 | 158 | 130 | 122 | 133 |
Total Common Shares Outstanding |